CEACAM5 and neoplasm: To compare the sensitivity and specificity between mSEPT9 and common tumor markers during the auxiliary diagnosis of CRC, pre-therapeutic CEA, CA 19–9 and CA724, serum levels were tested in 63 CRC patients and 60 subjects in NED group.